213 related articles for article (PubMed ID: 23822892)
21. Screening Cuts Ovarian Cancer Mortality.
Cancer Discov; 2016 Feb; 6(2):OF1. PubMed ID: 26758578
[TBL] [Abstract][Full Text] [Related]
22. Vignette-based study of ovarian cancer screening: do U.S. physicians report adhering to evidence-based recommendations?
Baldwin LM; Trivers KF; Matthews B; Andrilla CH; Miller JW; Berry DL; Lishner DM; Goff BA
Ann Intern Med; 2012 Feb; 156(3):182-94. PubMed ID: 22312138
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
[TBL] [Abstract][Full Text] [Related]
24. Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial.
Pinsky PF; Zhu C; Skates SJ; Black A; Partridge E; Buys SS; Berg CD
Int J Cancer; 2013 May; 132(9):2127-33. PubMed ID: 23065684
[TBL] [Abstract][Full Text] [Related]
25. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
[TBL] [Abstract][Full Text] [Related]
26. Population screening and early detection of ovarian cancer in asymptomatic women.
Nelson AE; Francis JE; Zorbas H;
Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):448-50. PubMed ID: 19780723
[TBL] [Abstract][Full Text] [Related]
27. Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up.
Pinsky PF; Yu K; Kramer BS; Black A; Buys SS; Partridge E; Gohagan J; Berg CD; Prorok PC
Gynecol Oncol; 2016 Nov; 143(2):270-275. PubMed ID: 27615399
[TBL] [Abstract][Full Text] [Related]
28. Utilization of ovarian cancer screening by women at increased risk.
Schwartz M; Lerman C; Daly M; Audrain J; Masny A; Griffith K
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):269-73. PubMed ID: 7606202
[TBL] [Abstract][Full Text] [Related]
29. Ovarian cancer screening-ultrasound; impact on ovarian cancer mortality.
Kamal R; Hamed S; Mansour S; Mounir Y; Abdel Sallam S
Br J Radiol; 2018 Oct; 91(1090):20170571. PubMed ID: 30102555
[TBL] [Abstract][Full Text] [Related]
30. Screening for ovarian cancer: is it worth the risk?
Bell R
Nurs Times; 1999 Jan 20-26; 95(3):52-3. PubMed ID: 10076394
[TBL] [Abstract][Full Text] [Related]
31. Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers.
Evans DG; Gaarenstroom KN; Stirling D; Shenton A; Maehle L; Dørum A; Steel M; Lalloo F; Apold J; Porteous ME; Vasen HF; van Asperen CJ; Moller P
J Med Genet; 2009 Sep; 46(9):593-7. PubMed ID: 18413372
[TBL] [Abstract][Full Text] [Related]
32. Screening women for ovarian cancer still does more harm than good.
Slomski A
JAMA; 2012 Jun; 307(23):2474-5. PubMed ID: 22797429
[No Abstract] [Full Text] [Related]
33. [Screening pelvic tumours for hereditary risk of ovarian neoplasms, a cancer center experience].
Taïeb S; Rocourt N; Narducci F; Leblanc E; Adenis C; Fournier C; Doutrelant P; Peyrat JP; Vennin P
Bull Cancer; 2011 Feb; 98(2):113-9. PubMed ID: 21339094
[TBL] [Abstract][Full Text] [Related]
34. Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation.
Menon U; Talaat A; Jeyarajah AR; Rosenthal AN; MacDonald ND; Skates SJ; Sibley K; Oram DH; Jacobs IJ
Br J Cancer; 1999 Jul; 80(10):1644-7. PubMed ID: 10408412
[TBL] [Abstract][Full Text] [Related]
35. The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer.
Bourne TH; Campbell S; Reynolds K; Hampson J; Bhatt L; Crayford TJ; Whitehead MI; Collins WP
Gynecol Oncol; 1994 Mar; 52(3):379-85. PubMed ID: 8157195
[TBL] [Abstract][Full Text] [Related]
36. A randomized study of screening for ovarian cancer: a multicenter study in Japan.
Kobayashi H; Yamada Y; Sado T; Sakata M; Yoshida S; Kawaguchi R; Kanayama S; Shigetomi H; Haruta S; Tsuji Y; Ueda S; Kitanaka T
Int J Gynecol Cancer; 2008; 18(3):414-20. PubMed ID: 17645503
[TBL] [Abstract][Full Text] [Related]
37. Ovarian cancer screening in women with a family history of breast or ovarian cancer.
Lacey JV; Greene MH; Buys SS; Reding D; Riley TL; Berg CD; Fagerstrom RM; Hartge P
Obstet Gynecol; 2006 Nov; 108(5):1176-84. PubMed ID: 17077240
[TBL] [Abstract][Full Text] [Related]
38. The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: Performance and complications.
Doroudi M; Kramer BS; Pinsky PF
J Med Screen; 2017 Dec; 24(4):220-222. PubMed ID: 27903809
[TBL] [Abstract][Full Text] [Related]
39. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Fenton JJ; Weyrich MS; Durbin S; Liu Y; Bang H; Melnikow J
JAMA; 2018 May; 319(18):1914-1931. PubMed ID: 29801018
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
